In this seventeenth episode, Gordon Lauc introduces glycobiology. He details GlycanAge®, the world’s first direct-to-consumer glycan-based product. He explains that it can quantify how well interventions (e.g. supplements) work for you as an individual, and how much healthy life you’ve got left. Finally he details a potential COVID-19 glycan biomarker to accurately assess your risk.
Lee: Hello Gordan, and welcome to the 17th episode of the Quantified Health, Wellness, and Aging podcast. Gordan: Hi Lee, thank you for the invitation. Lee: Most appreciated. I was surprised that you’re over in Zagreb, which is, I would say about less than 90 minutes away from where I am. Gordan: Well, Zagreb is a nice location. It has... Read MoreMeasure Glycans to Know How Much Healthy Life You’ve Already Consumed – EP17: Gordan Lauc (Genos)
In this tenth episode, Jeremy Malecha discusses his company plans to democratize and scale functional medicine by more effective data processing. He discusses the need to consolidate data across hundreds of lab test lab providers, structuring of that data and finally the ability to better leverage the data. He discusses his own personal health journey along the way.
Lee: Hello and welcome. On today’s show we have Jeremy Malecha, hopefully I pronounced that okay. It will be an ad lib conversation without any pre agreed structure or topics. We’ve agreed only to talk around the focus of Jeremy’s company, which is streamlining functional medicine starting with data consolidation. Lee: Jeremy is the CEO and co-founder of Biocanic with... Read MoreStreamlining Functional Medicine Starting With Data Consolidation – EP10: Jeremy Malecha (Biocanic)
In this sixth episode, Tommy Wood, CSO Nourish Balance Thrive, explains that the majority of modern disease is caused by our environment and as such, under our control. He shares his experience that A.I. coupled with ordinary blood tests, can inform us of changes we can make to protect/optimize our health, or when sick, lower the cost by predicting which further tests to conduct.
Lee: Hello, and welcome to the Hyper Wellbeing podcast, Tommy. Tommy: Oh, thanks for having me. Lee: Tommy, let’s just jump in here. You still look young, you’ve got a fantastic resume, or as the British would say, I think, curriculum vitae. Where is the motivation coming from? What’s your driving force? What’s the mission you’re on? Tommy: I guess... Read MoreEngineering Sustained Health Using A.I. & Standard Blood Chemistry – EP06: Tommy Wood (NBT)
In this fifth episode, Don Brown, CEO LifeOmic, explains the nomenclature shift from precision medicine to precision health, details the firm footing his company has in precision health, how it’s now extending another foot forwards into hyper wellbeing. Lots of app, lifestyle medicine, lifespan, healthspan and biological age quantification chat.
Lee: Hi, so you’re CEO of LifeOmic, a company which I have been tracking for some time. Could you be so kind as to introduce, to give a brief introduction to LifeOmic? Don: Yeah, I started LifeOmic almost two or so years ago. I went through a combined degree in the PhD program many years ago and ended up taking... Read MorePrecision Medicine vs Precision Health vs Hyper Wellbeing – EP05: Don Brown (LifeOmic)
In this second episode, Joseph Antoun, Chairman of the Board and CEO of L-Nutra Incorporated, shares his personal mission to grow the concept of biological aging. He describes his vision that by quantifying biological age and by pushing for its widespread adoption, new lucrative and transformative markets will be created.
Lee: Hello and welcome to the second episode of the Hyper Wellbeing podcast. On today’s show we have professor Joseph Antoun. Joseph is a Chairman of the Board and CEO of L-Nutra Incorporated, a nutritech company developing Fast Mimicking Diets (FMDs) aimed and preventing, intercepting, and reversing age related diseases. He’s also co-director of the Center for Health Policy at... Read MoreFasting Mimicking Diets, Biological Aging and Longevity – EP02: Joseph Antoun (L-Nutra)